Management of a pure uterine corpus rhabdomyosarcoma in a postmenopausal patient: A rare case report and review of the literature.
John LugataCaleigh SmithOnesmo MrossoDoris RwenyagilaBaraka ShaoDoris SchledermannPublished in: Clinical case reports (2024)
Rhabdomyosarcoma (RMS) is a malignant mesenchymal neoplasm with a tendency to differentiate into skeletal muscle cells. RMS is an aggressive tumor that tends to develop in children and younger patients. A vast majority of genital tract RMSs occur in the vagina and cervix. Such tumors rarely occur in adults. Usually, these tumors either occur as a component of a biphasic uterine tumor (carcinosarcoma or adenosarcoma) or can be a pure heterologous tumor. Pure uterine RMSs are extremely rare in adult patients and difficult to diagnose. Accurate diagnosis of these tumors depends on precise histopathological evaluation. The present report describes a rare case of embryonal RMS of the uterus in a postmenopausal female and explores the most recent literature. The aim is to strengthen the existing literature and aid clinicians in the management of similar cases. A 64-year-old postmenopausal female presented with a history of abdominal pain associated with abdominal distension, per vaginal bleeding, and foul-smelling discharge for 6 months. A transabdominal ultrasound revealed a bulky uterus with a well-circumscribed heterogeneous lesion. Histopathology confirmed the diagnosis of high-grade embryonal RMS within the corpus region of the uterus. A total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed, followed by adjuvant chemotherapy to prevent relapse of the disease. Six months after oncological care has passed, the patient remains symptoms-free without evidence of recurrence or metastasis.
Keyphrases
- high grade
- rare case
- skeletal muscle
- systematic review
- bone mineral density
- case report
- abdominal pain
- end stage renal disease
- palliative care
- low grade
- healthcare
- induced apoptosis
- magnetic resonance imaging
- breast cancer risk
- newly diagnosed
- insulin resistance
- stem cells
- ejection fraction
- rectal cancer
- young adults
- prostate cancer
- adipose tissue
- peritoneal dialysis
- atrial fibrillation
- cell cycle arrest
- quality improvement
- prognostic factors
- physical activity
- mass spectrometry
- cell death
- free survival
- body composition
- endoplasmic reticulum stress
- computed tomography
- health insurance
- replacement therapy
- cell proliferation
- type diabetes
- depressive symptoms
- radical prostatectomy